RAAPID Secures $6.7 Million in Series A Funding to Accelerate Growth of Innovative Risk Adjustment Platform

We are excited to announce that RAAPID has successfully raised $6.7 million in a recent funding round, a significant boost that will propel our mission to revolutionize risk adjustment in healthcare.

As a full-stack, end-to-end risk adjustment platform, RAAPID is dedicated to delivering guaranteed compliant return on investment for our clients while simultaneously reducing costs and improving accuracy in the complex world of risk adjustment programs.

Our advanced solutions not only mitigate the risks associated with Office of Inspector General (OIG) and Risk Adjustment Data Validation (RADV) audits but also enhance the overall experience for healthcare providers by reducing physician abrasion.

The infusion of this new capital will allow us to further develop our innovative offerings that include audit, retrospective, and prospective risk adjustment solutions, leveraging our unique Neuro-Symbolic AI technology.

By augmenting near-human reasoning, our AI acts as an invaluable assistant to coders and providers, streamlining processes and enhancing decision-making capabilities.

With these funds, RAAPID aims to expand our team, improve our technology, and extend our reach within the healthcare market.

We believe that with the right resources, we can continue to refine our platform, ensuring that risk adjustment is not just compliant but also effective, accurate, and capable of delivering the highest standard of care.

As we embark on this exciting new chapter, we are grateful for our investors' support and look forward to making a significant impact in the healthcare sector.

Stay tuned for the next phase of our journey!